BerganKDV Wealth Management’s Idexx Laboratories IDXX Stock Holding History

BerganKDV Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$437K	Sell	870 -129	-13%	-$61.8K	0.04%	174
2023 Q1	$500K	Sell	999 -120	-11%	-$57.4K	0.05%	171
2022 Q4	$457K	Hold	1,119	–	–	0.05%	171
2022 Q3	$365K	Hold	1,119	–	–	0.04%	189
2022 Q2	$392K	Sell	1,119 -204	-15%	-$83.2K	0.04%	193
2022 Q1	$724K	Sell	1,323 -116	-8%	-$61K	0.08%	151
2021 Q4	$948K	Buy	1,439 +136	+10%	+$85.4K	0.1%	134
2021 Q3	$810K	Hold	1,303	–	–	0.09%	137
2021 Q2	$823K	Hold	1,303	–	–	0.1%	131
2021 Q1	$638K	Sell	1,303 -157	-11%	-$78.7K	0.08%	153
2020 Q4	$730K	Sell	1,460 -130	-8%	-$58.2K	0.1%	122
2020 Q3	$625K	Hold	1,590	–	–	0.1%	134
2020 Q2	$525K	Sell	1,590 -1	-0.1%	-$290	0.09%	140
2020 Q1	$385K	Hold	1,591	–	–	0.08%	153
2019 Q4	$415K	Sell	1,591 -285	-15%	-$75.1K	0.07%	167
2019 Q3	$510K	Sell	1,876 -124	-6%	-$34.5K	0.1%	131
2019 Q2	$551K	Buy	+2,000	New	+$493K	0.11%	133

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

BerganKDV Wealth Management's IDXX Position: Q2 2023 in Review

BerganKDV Wealth Management reduced its Idexx Laboratories (IDXX) stake by 13% in Q2 2023, selling an estimated $61.8K and leaving 870 shares worth $437K. The position accounts for 0.04% of the portfolio, ranked #174.

BerganKDV Wealth Management first reported a position in IDXX in Q2 2019 and has held it in 17 quarters since. The position peaked at $948K in Q4 2021. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

BerganKDV Wealth Management held 870 shares of Idexx Laboratories worth $437K as of Q2 2023.
BerganKDV Wealth Management sold 129 Idexx Laboratories shares in Q2 2023, an estimated $61.8K.
Idexx Laboratories made up 0.04% of BerganKDV Wealth Management's portfolio in Q2 2023, its #174 holding.
BerganKDV Wealth Management first reported a position in Idexx Laboratories in Q2 2019 and has held it in 17 quarters since.
BerganKDV Wealth Management's Idexx Laboratories position peaked at $948K in Q4 2021.
1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.